RABBANI ELAZAR has a total of 33 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, organic fine chemistry and measurement are CENTRILLION TECH HOLDINGS CORPORATION, DNA CHIP RESEARCH INC and CENTRILLION TECH HOLDINGS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 33 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Chemical engineering | |
#5 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Sugars | |
#5 | Organic chemistry methods | |
#6 | Chemical or physical processes | |
#7 | Combinatorial chemistry | |
#8 | Fermentation | |
#9 | Therapeutic chemical compounds | |
#10 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Rabbani Elazar | 33 |
#2 | Donegan James J | 31 |
#3 | Stavrianopoulos Jannis G | 28 |
#4 | Coleman Jack | 21 |
#5 | Liu Dakai | 8 |
#6 | Walner Marleen | 5 |
#7 | Engelhardt Dean L | 3 |
#8 | Kelker Norman E | 2 |
#9 | Keller Norman E | 1 |
#10 | Patton Wayne | 1 |
Publication | Filing date | Title |
---|---|---|
US2012252007A1 | Optimized real time nucleic acid detection processes | |
US2012052481A1 | Assays for detecting modified compounds | |
US2011105606A1 | Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain | |
US2009162845A1 | Affinity tag nucleic acid and protein compositions, and processes for using same | |
US2007281863A1 | Dual polarity analysis of nucleic acids | |
US2008070241A1 | Kits for amplifying and detecting nucleic acid sequences | |
US9261460B2 | Real-time nucleic acid detection processes and compositions |